The Peter Lamy Center on Drug Therapy and Aging conducts research on policy and clinically relevant issues regarding optimal medication use among older adults.

The Center challenges established beliefs by using traditional research methods in innovative ways. Current focal areas include:

  • Falls Prevention
  • Psychopharmacological Medication Use, Quality, and Outcomes
  • Substance Use and Mental Health Disorders
  • Multi-Morbidity
  • Medication Therapy Management—Policy and Practice Implications
Dr. Linda Wastila Receives $1.6 Million Grant from the National Institutes of Health

Study aims to understand how a nationwide effort to reduce the use of antipsychotics in long-term care facilities has impacted use of other medications and patient health outcomes.

Read More

Data, science, and art drive research at the Lamy Center.

We utilize multiple data sources in our work, including:

  • Chronic Condition Data Warehouse (CCW): Medicare claims data spanning 2006–2015
  • Medicare Current Beneficiary Survey: National survey through 2013
  • Minimum Data Set: Nursing home survey linked to CCW and MCBS
  • IMS LifeLink Data: Private insurance data spanning 2006–2015
  • Other private and public use data sources

The science in Lamy Center research initiatives derives from the meticulous care and cutting-edge methodological approaches scientists take in their studies. Faculty, staff, and students in the Lamy Center not only have clinical backgrounds, but also training in epidemiology, policy, economics, and health services research.

The art in science consists of posing the right questions, selecting the best methods and data sources, applying appropriate analytic techniques, and properly interpreting research results. Lamy Center members publish well and widely, and regularly present at national and international conferences.

Research funding comes from government agencies, state government, private foundations, and for-profit corporations. To find out more about the Lamy Center’s resources and how to be involved in the Lamy research mission, please contact: Linda Wastila, BSPharm, MSPH, PhD.